“…The majority of these studies have focused on: (a) synthesis and initial evaluation of new photosensitizers; (b) identification of subcellular targets involved in PDT cytotoxicity; (c) evaluation and comparison of photosensitizer localiza1.ion and cytotoxicity for normal and malignant cells,; (d) defining in vivo treatment parameters associated with PDT toxicity; (e) determining normal tissue responses following PDT; and (f) documenting in vivo targets and systemic responses associated with PDT. For a comprehensive background on various PDT topics examined over the past 8-10 years, the reader may wish to scan previous Yearly Reviews written by Kessel (1984), Moan (1986), Spikes (1986), Dougherty (1987), Sieber (1987), Girotti (1990) and Rosenthal (1991). Additional background material on PDT can also be obtained from s,pecific books edited by Kessel and Dougherty (1'983), Doiron and Gomer (1984), Andreoni and Cubeddu (1984), Kessel (1985), Jori and Perria (1985), Gomer *Abbreviations: BPD, benzoporphyrin derivative; ET2, etiopurpurin; HP, hematoporphyrin; HPD, hematoporphyrin derivative; H S V , Herpessimplex virus; LDL, low density lipoprotein; MC-540, merocyaniine 540; NMR, nuclear magnetic resonance; NPe6, mono-I-aspartyl chlorin e6; NT2, octaethylpurpurin; O,, singlet oxygen; PC, phthalocyanine; PDT, photodynami'c therapy; RIF, radiation induced fibrosarcoma.…”